CG
BLFS icon

Cutler Group’s BioLife Solutions BLFS Stock Holding History

Cutler Group’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10,000
Closed -$5K – 5698
2021
Q1 		$5K Buy
10,000
+8,600
+614% +$340K ﹤0.01% 4336
2020
Q4 		$7K Buy
1,400
+700
+100% +$23.9K ﹤0.01% 3408
2020
Q3 		$7K Buy
700
+400
+133% +$8.64K ﹤0.01% 3222
2020
Q2 		$1K Buy
+300
New +$4.14K ﹤0.01% 3955

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cutler Group's BLFS Position: Q1 2021 in Review

Cutler Group sold out of BioLife Solutions (BLFS) in Q1 2021, closing a stake of 400 shares — an estimated $15.8K sold.

Cutler Group first reported a position in BLFS in Q4 2019 and held it in 4 quarters. The position peaked at $15K in Q4 2020. 132 funds tracked by Wall St. Rank hold BLFS as of Q1 2021.

  • Cutler Group reported no remaining BioLife Solutions position as of Q1 2021 after selling out during the quarter.
  • Cutler Group sold 400 BioLife Solutions shares in Q1 2021, an estimated $15.8K.
  • Cutler Group first reported a position in BioLife Solutions in Q4 2019 and held it in 4 quarters.
  • Cutler Group's BioLife Solutions position peaked at $15K in Q4 2020.
  • 132 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2021.

Based on Cutler Group's 13F filing for Q1 2021, filed 26 Apr 2021.